Immediate Impact
14 from Science/Nature 72 standout
Citing Papers
Trastuzumab Deruxtecan after Endocrine Therapy in Metastatic Breast Cancer
2024 Standout
Computational approaches streamlining drug discovery
2023 StandoutNature
Works of Alfonso de Dios being referenced
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer
2017
Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine
2014 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Alfonso de Dios | 930 | 438 | 990 | 490 | 37 | 1.8k | |
| Carolyn Discafani | 563 | 864 | 1391 | 1393 | 30 | 3.0k | |
| Jon Curwen | 622 | 487 | 995 | 1465 | 31 | 2.7k | |
| William L. Elliott | 834 | 538 | 1301 | 948 | 43 | 2.3k | |
| Blake Lee Neubauer | 1005 | 221 | 794 | 1443 | 55 | 2.9k | |
| Gerd Bader | 956 | 266 | 831 | 1436 | 50 | 2.6k | |
| Anne T. Truesdale | 493 | 398 | 953 | 1045 | 16 | 2.3k | |
| Yiqun Li | 454 | 238 | 668 | 857 | 24 | 1.7k | |
| Laurent Hennequin | 493 | 769 | 961 | 1465 | 51 | 2.7k | |
| Jinee Rizzo | 639 | 112 | 1179 | 647 | 26 | 1.8k | |
| Andrea Cavazzoni | 976 | 406 | 1186 | 1111 | 75 | 2.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...